Advertisement
[adinserter block="11" template="Global Header" check="exceptions" ignore="page-type"]

HIV/AIDS

June 2020 Briefing – HIV & AIDS

Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for June 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and...

Read More

FDA Approves Dolutegravir for Kids with HIV-1

Tablets indicated for children as young as 4 weeks WASHINGTON — The FDA approved dolutegravir (Tivicay, tablets; Tivicay PD, tablets for oral suspension) in combination with other antiretroviral treatments for pediatric...

Read More

May 2020 Briefing – HIV & AIDS

Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for May 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and...

Read More

For latest news and updates
Email-id is invalid